Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Leukemia 5Leukemia, Myeloid, Acute 3Recurrence 2Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoproliferative Disorders 1Lymphoma 1Leukemia, Biphenotypic, Acute 1Immunoproliferative Disorders 1Hypersensitivity 1Down Syndrome 1

Interventions

Whole-Body Irradiation 14Mycophenolic Acid 14fludarabine phosphate 13Cyclophosphamide 13Cytarabine 11Methotrexate 9Granulocyte Colony-Stimulating Factor 9Filgrastim 9Cyclosporine 8Peripheral Blood Stem Cell Transplantation 7Vincristine 6Thiotepa 6Tacrolimus 6Dexamethasone 6Cord Blood Stem Cell Transplantation 6merphos 5fludarabine 5Mitoxantrone 5Clofarabine 5Calcium Dobesilate 5Busulfan 5Mercaptopurine 4Melphalan 4Leucovorin 4Cladribine 4pegaspargase 3dexamethasone acetate 3dexamethasone 21-phosphate 3auricularum 3Specimen Handling 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Biphenotypic, Acute × asparaginase erwinia chrysanthemi recombinant × Clear all
NCT02419755 2018-03-07

Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 2 Terminated
12 enrolled 10 charts
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡